SABRTOOTH: a feasibility study of SABR versus surgery in patients with peripheral stage I NSCLC considered to be at higher risk for surgery
Authors
Franks, KMcparland, L
Webster, J
Baldwin, D
Sebag-Montefiore, D
Evison, M
Booton, R
Faivre-Finn, Corinne
Naidu, B
Ferguson, J
Peedell, C
Canister, M
Kennedy, M
Gregory, W
Hewison, J
Bestall, J
Bell, S
Hall, P
Snee, M
Affiliation
Clinical Oncology, Leeds Cancer Centre, St James's University Hospital, Leeds, UKIssue Date
2018
Metadata
Show full item recordCitation
Franks K, McParland L, Webster J, Baldwin D, Sebag-Montefiore D, Evison M, et al. P2.16-16 SABRTOOTH: a feasibility study of SABR versus surgery in patients with peripheral stage I NSCLC considered to be at higher risk for surgery. J Thorac Oncol. 2018;13(10):S837.Journal
Journal of Thoracic OncologyDOI
10.1016/j.jtho.2018.08.1491Additional Links
https://dx.doi.org/10.1016/j.jtho.2018.08.1491Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.jtho.2018.08.1491